drugset / Trial / NCT04765462
Allogeneic γδ T Cell Therapy for the Treatment of Solid Tumors
NaSingle-groupOpen-labelTreatment
Summary
The study is to determine the safety, feasibility and efficacy of allogeneic γδ T cell therapy in patients with solid tumors.
Timeline
- Start
- 2021-03-01
- Primary completion
- 2023-12-31
- Completion
- 2024-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Allogeneic γδT cells | Cell therapy | 2e+06 cells/kg | — |
| Subject | Allogeneic γδT cells | Cell therapy | 1e+07 cells/kg | — |
| Subject | Allogeneic γδT cells | Cell therapy | 5e+07 cells/kg | — |